| RS2483307125 |
COL9A1
|
Health Risk |
Likely pathogenic |
— |
| RS2483311809 |
INTS1
|
Health Risk |
Pathogenic |
— |
| RS2483312174 |
COL9A1
|
Health Risk |
Likely pathogenic |
COL9A1-related disorder, COL9A1-related disorder |
| RS2483312751 |
COL9A1
|
Health Risk |
Pathogenic |
— |
| RS2483318507 |
CYP21A2
|
Health Risk |
Likely pathogenic |
— |
| RS2483321372 |
GABBR1
|
Health Risk |
Likely pathogenic |
Delayed speech and language development, Intellectual disability |
| RS2483321731 |
CYP21A2
|
Health Risk |
Pathogenic |
— |
| RS2483326407 |
CYP21A2
|
Health Risk |
Pathogenic |
— |
| RS2483329842 |
CYP21A2
|
Health Risk |
Likely pathogenic |
— |
| RS2483339912 |
GABBR1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2483345536 |
DLL1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures, Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures |
| RS2483346002 |
DLL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures, Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures |
| RS2483346100 |
DLL1
|
Health Risk |
Likely pathogenic |
— |
| RS2483346143 |
DLL1
|
Health Risk |
Pathogenic |
— |
| RS2483346798 |
DLL1
|
Health Risk |
Pathogenic |
— |
| RS2483347067 |
DLL1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures, Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures |
| RS2483347423 |
DLL1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures, Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures |
| RS2483348338 |
DLL1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures, Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures |
| RS2483348372 |
DLL1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures, Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures |
| RS2483348418 |
TAB2
|
Health Risk |
Likely pathogenic |
TAB2-related disorder, TAB2-related disorder |
| RS2483350170 |
DLL1
|
Health Risk |
Pathogenic |
— |
| RS2483351030 |
DLL1
|
Health Risk |
Pathogenic |
— |
| RS2483351391 |
DLL1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures, Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures |
| RS2483352410 |
DLL1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures, Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures |
| RS2483357984 |
DLL1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures, Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures |
| RS2483358114 |
DLL1
|
Health Risk |
Pathogenic |
— |
| RS2483358297 |
DLL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures, Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures |
| RS2483358646 |
DLL1
|
Health Risk |
Likely pathogenic |
DLL1-related disorder, DLL1-related disorder |
| RS2483359338 |
TNXB
|
Health Risk |
Likely pathogenic |
— |
| RS2483362480 |
DLL1
|
Health Risk |
Likely pathogenic |
— |
| RS2483362657 |
DLL1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures, Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures |
| RS2483362975 |
RARS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS2483363120 |
DLL1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures, Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures |
| RS2483363365 |
DLL1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures, Neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures |
| RS2483363426 |
DLL1
|
Health Risk |
Pathogenic |
— |
| RS2483363823 |
RARS2
|
Health Risk |
Pathogenic |
— |
| RS2483364598 |
TNXB
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome due to tenascin-X deficiency, Ehlers-Danlos syndrome due to tenascin-X deficiency |
| RS2483365234 |
INTS1
|
Health Risk |
Pathogenic |
— |
| RS2483367033 |
RARS2
|
Health Risk |
Pathogenic |
— |
| RS2483370839 |
BCKDHB
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2483372241 |
HACE1
|
Health Risk |
Pathogenic |
Spastic paraplegia-severe developmental delay-epilepsy syndrome, Spastic paraplegia-severe developmental delay-epilepsy syndrome |
| RS2483384714 |
TAB2
|
Health Risk |
Pathogenic |
— |
| RS2483385177 |
TAB2
|
Health Risk |
Pathogenic |
Congenital heart defects, multiple types |
| RS2483385319 |
TAB2
|
Health Risk |
Pathogenic |
Congenital heart defects, multiple types |
| RS2483385755 |
ENPP1
|
Health Risk |
Likely pathogenic |
Hypophosphatemic rickets, autosomal recessive |
| RS2483386092 |
TAB2
|
Health Risk |
Pathogenic |
Congenital heart defects, multiple types |
| RS2483386574 |
TAB2
|
Health Risk |
Pathogenic |
— |
| RS2483386818 |
TAB2
|
Health Risk |
Likely pathogenic |
Congenital heart defects, multiple types |
| RS2483387310 |
COL9A1
|
Health Risk |
Likely pathogenic |
— |
| RS2483387574 |
TAB2
|
Health Risk |
Pathogenic |
— |
| RS2483388628 |
TAB2
|
Health Risk |
Pathogenic |
— |
| RS2483390825 |
TAB2
|
Health Risk |
Pathogenic |
— |
| RS2483392059 |
TAB2
|
Health Risk |
Pathogenic |
Congenital heart defects, multiple types |
| RS2483392655 |
TAB2
|
Health Risk |
Pathogenic |
Congenital heart defects, multiple types |
| RS2483392842 |
COL9A1
|
Health Risk |
Likely pathogenic |
— |
| RS2483393160 |
TAB2
|
Health Risk |
Pathogenic |
Congenital heart defects, multiple types |
| RS2483395150 |
TAB2
|
Health Risk |
Pathogenic |
— |
| RS2483396559 |
TAB2
|
Health Risk |
Pathogenic |
— |
| RS2483396825 |
TAB2
|
Health Risk |
Likely pathogenic |
— |
| RS2483397187 |
COL9A1
|
Health Risk |
Pathogenic |
— |
| RS2483397256 |
TAB2
|
Health Risk |
Likely pathogenic |
Congenital heart defects, multiple types |
| RS2483397661 |
TAB2
|
Health Risk |
Pathogenic |
Congenital heart defects, multiple types |
| RS2483398618 |
TAB2
|
Health Risk |
Likely pathogenic |
Congenital heart defects, multiple types |
| RS2483399171 |
TAB2
|
Health Risk |
Pathogenic |
Congenital heart defects, multiple types |
| RS2483399410 |
TAB2
|
Health Risk |
Pathogenic |
— |
| RS2483399424 |
TAB2
|
Health Risk |
Pathogenic |
— |
| RS2483399715 |
TAB2
|
Health Risk |
Pathogenic |
Congenital heart defects, multiple types |
| RS2483400097 |
TAB2
|
Health Risk |
Likely pathogenic |
Congenital heart defects, multiple types |
| RS2483415527 |
TNXB
|
Health Risk |
Pathogenic |
— |
| RS2483424286 |
TNXB
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome due to tenascin-X deficiency, Ehlers-Danlos syndrome due to tenascin-X deficiency |
| RS2483425306 |
COL9A1
|
Health Risk |
Likely pathogenic |
Stickler syndrome, Stickler syndrome |
| RS2483451503 |
THBS2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic-like |
| RS2483454633 |
TNXB
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2483454898 |
COL9A1
|
Health Risk |
Likely pathogenic |
— |
| RS2483455914 |
COL9A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Epiphyseal dysplasia, multiple |
| RS2483456409 |
COL9A1
|
Health Risk |
Likely pathogenic |
— |
| RS2483459179 |
COL9A1
|
Health Risk |
Pathogenic |
— |
| RS2483459746 |
ENPP1
|
Health Risk |
Likely pathogenic |
— |
| RS2483459984 |
COL9A1
|
Health Risk |
Pathogenic |
— |
| RS2483462090 |
ENPP1
|
Health Risk |
Likely pathogenic |
ENPP1-related disorder, ENPP1-related disorder |
| RS2483462219 |
SERAC1
|
Health Risk |
Likely pathogenic |
SERAC1-related neurological disorder, SERAC1-related neurological disorder |
| RS2483467270 |
COL9A1
|
Health Risk |
Pathogenic |
— |
| RS2483469257 |
COL9A1
|
Health Risk |
Likely pathogenic |
— |
| RS2483472550 |
COL9A1
|
Health Risk |
Pathogenic |
— |
| RS2483477141 |
ENPP1
|
Health Risk |
Likely pathogenic |
— |
| RS2483477529 |
SERAC1
|
Health Risk |
Likely pathogenic |
3-methylglutaconic aciduria with deafness, encephalopathy |
| RS2483486828 |
TAB2
|
Health Risk |
Likely pathogenic |
Congenital heart defects, multiple types |
| RS2483489255 |
TAB2
|
Health Risk |
Pathogenic |
Congenital heart defects, multiple types |
| RS2483496829 |
ENPP1
|
Health Risk |
Pathogenic |
— |
| RS2483500296 |
COL9A1
|
Health Risk |
Pathogenic |
— |
| RS2483504427 |
BLTP1
|
Health Risk |
Pathogenic |
Alkuraya-Kucinskas syndrome, Alkuraya-Kucinskas syndrome |
| RS2483510755 |
ENPP1
|
Health Risk |
Likely pathogenic |
ENPP1-related disorder, ENPP1-related disorder |
| RS2483513145 |
ENPP1
|
Health Risk |
Likely pathogenic |
Hypophosphatemic rickets, autosomal recessive |
| RS2483527612 |
ENPP1
|
Health Risk |
Pathogenic |
Arterial calcification, generalized |
| RS2483528312 |
COL9A1
|
Health Risk |
Likely pathogenic |
— |
| RS2483530034 |
ENPP1
|
Health Risk |
Pathogenic |
— |
| RS2483532756 |
ENPP1
|
Health Risk |
Likely pathogenic |
— |
| RS2483538013 |
RARS2
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS2483538120 |
RARS2
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS2483547484 |
ENPP1
|
Health Risk |
Likely pathogenic |
Arterial calcification, generalized |